APO Research
Talk to an analyst

APO RESEARCH · REPORT

CAR-T Cell Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global CAR-T Cell Service Market Analysis and Forecast 2026-2032

4 June 2026239 pages

Choose your research edition.

Industry ResearchCAR-T Cell Service Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal CAR-T Cell Service Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal CAR-T Cell Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CAR-T Cell Service Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal CAR-T Cell Service Market Analysis and Forecast 2026-2032239 pages · $4,950 USD

Market perspective

The global CAR-T Cell Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for CAR-T Cell Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for CAR-T Cell Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for CAR-T Cell Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for CAR-T Cell Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of CAR-T Cell Service include Aurigene Pharmaceutical Services Ltd, Cellipont Bioservices, ProBio, Creative Biolabs, Charles River Laboratories, Cytiva, Sino Biological, Inc, Miltenyi Biotec and ProMab Biotechnologies, Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for CAR-T Cell Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of CAR-T Cell Service, also provides the revenue of main regions and countries. Of the upcoming market potential for CAR-T Cell Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the CAR-T Cell Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global CAR-T Cell Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for CAR-T Cell Service revenue, projected growth trends, production technology, application and end-user industry.

CAR-T Cell Service Segment by Company

Aurigene Pharmaceutical Services Ltd

Cellipont Bioservices

ProBio

Creative Biolabs

Charles River Laboratories

Cytiva

Sino Biological, Inc

Miltenyi Biotec

ProMab Biotechnologies, Inc

Creative Biogene

BPS Bioscience, Inc

Reaction Biology

Cusabio Technology LLC

Oncodesign Services

ACROBiosystems

Kite Pharma, Inc

sartorius

WuXi ATU Co

CAR-T Cell Service Segment by Type

Development Services

Manufacturing Services

Other

CAR-T Cell Service Segment by Application

Clinical Research

Clinical Treatment

Other

CAR-T Cell Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CAR-T Cell Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CAR-T Cell Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CAR-T Cell Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of CAR-T Cell Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of CAR-T Cell Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CAR-T Cell Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global CAR-T Cell Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Development Services Major Player Table 3. Manufacturing Services Major Player Table 4. Other Major Player Table 5. Global CAR-T Cell Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinical Research Major Player Table 7. Clinical Treatment Major Player Table 8. Other Major Player Table 9. CAR-T Cell Service Industry Trends Table 10. CAR-T Cell Service Industry Drivers Table 11. CAR-T Cell Service Industry Opportunities and Challenges Table 12. CAR-T Cell Service Industry Restraints Table 13. Global CAR-T Cell Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global CAR-T Cell Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global CAR-T Cell Service Market Share by Region (2021-2026) Table 16. Global CAR-T Cell Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global CAR-T Cell Service Market Share by Region (2027-2032) Table 18. Global CAR-T Cell Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global CAR-T Cell Service Revenue Market Share by Players (2021-2026) Table 20. Global CAR-T Cell Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global CAR-T Cell Service Key Players Headquarters & Area Served Table 22. Global CAR-T Cell Service Players, Product Type & Application Table 23. Global CAR-T Cell Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global CAR-T Cell Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global CAR-T Cell Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global CAR-T Cell Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global CAR-T Cell Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global CAR-T Cell Service Revenue Market Share by Type (2021-2026) Table 30. Global CAR-T Cell Service Revenue Market Share by Type (2027-2032) Table 31. Global CAR-T Cell Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global CAR-T Cell Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global CAR-T Cell Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global CAR-T Cell Service Revenue Market Share by Application (2021-2026) Table 35. Global CAR-T Cell Service Revenue Market Share by Application (2027-2032) Table 36. Aurigene Pharmaceutical Services Ltd Company Information Table 37. Aurigene Pharmaceutical Services Ltd Business Overview Table 38. Aurigene Pharmaceutical Services Ltd CAR-T Cell Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Aurigene Pharmaceutical Services Ltd CAR-T Cell Service Product Portfolio Table 40. Aurigene Pharmaceutical Services Ltd Recent Development Table 41. Cellipont Bioservices Company Information Table 42. Cellipont Bioservices Business Overview Table 43. Cellipont Bioservices CAR-T Cell Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Cellipont Bioservices CAR-T Cell Service Product Portfolio Table 45. Cellipont Bioservices Recent Development Table 46. ProBio Company Information Table 47. ProBio Business Overview Table 48. ProBio CAR-T Cell Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. ProBio CAR-T Cell Service Product Portfolio Table 50. ProBio Recent Development Table 51. Creative Biolabs Company Information Table 52. Creative Biolabs Business Overview Table 53. Creative Biolabs CAR-T Cell Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Creative Biolabs CAR-T Cell Service Product Portfolio Table 55. Creative Biolabs Recent Development Table 56. Charles River Laboratories Company Information Table 57. Charles River Laboratories Business Overview Table 58. Charles River Laboratories CAR-T Cell Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Charles River Laboratories CAR-T Cell Service Product Portfolio Table 60. Charles River Laboratories Recent Development Table 61. Cytiva Company Information Table 62. Cytiva Business Overview Table 63. Cytiva CAR-T Cell Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Cytiva CAR-T Cell Service Product Portfolio Table 65. Cytiva Recent Development Table 66. Sino Biological, Inc Company Information Table 67. Sino Biological, Inc Business Overview Table 68. Sino Biological, Inc CAR-T Cell Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Sino Biological, Inc CAR-T Cell Service Product Portfolio Table 70. Sino Biological, Inc Recent Development Table 71. Miltenyi Biotec Company Information Table 72. Miltenyi Biotec Business Overview Table 73. Miltenyi Biotec CAR-T Cell Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Miltenyi Biotec CAR-T Cell Service Product Portfolio Table 75. Miltenyi Biotec Recent Development Table 76. ProMab Biotechnologies, Inc Company Information Table 77. ProMab Biotechnologies, Inc Business Overview Table 78. ProMab Biotechnologies, Inc CAR-T Cell Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. ProMab Biotechnologies, Inc CAR-T Cell Service Product Portfolio Table 80. ProMab Biotechnologies, Inc Recent Development Table 81. Creative Biogene Company Information Table 82. Creative Biogene Business Overview Table 83. Creative Biogene CAR-T Cell Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Creative Biogene CAR-T Cell Service Product Portfolio Table 85. Creative Biogene Recent Development Table 86. BPS Bioscience, Inc Company Information Table 87. BPS Bioscience, Inc Business Overview Table 88. BPS Bioscience, Inc CAR-T Cell Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. BPS Bioscience, Inc CAR-T Cell Service Product Portfolio Table 90. BPS Bioscience, Inc Recent Development Table 91. Reaction Biology Company Information Table 92. Reaction Biology Business Overview Table 93. Reaction Biology CAR-T Cell Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Reaction Biology CAR-T Cell Service Product Portfolio Table 95. Reaction Biology Recent Development Table 96. Cusabio Technology LLC Company Information Table 97. Cusabio Technology LLC Business Overview Table 98. Cusabio Technology LLC CAR-T Cell Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Cusabio Technology LLC CAR-T Cell Service Product Portfolio Table 100. Cusabio Technology LLC Recent Development Table 101. Oncodesign Services Company Information Table 102. Oncodesign Services Business Overview Table 103. Oncodesign Services CAR-T Cell Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Oncodesign Services CAR-T Cell Service Product Portfolio Table 105. Oncodesign Services Recent Development Table 106. ACROBiosystems Company Information Table 107. ACROBiosystems Business Overview Table 108. ACROBiosystems CAR-T Cell Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. ACROBiosystems CAR-T Cell Service Product Portfolio Table 110. ACROBiosystems Recent Development Table 111. Kite Pharma, Inc Company Information Table 112. Kite Pharma, Inc Business Overview Table 113. Kite Pharma, Inc CAR-T Cell Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Kite Pharma, Inc CAR-T Cell Service Product Portfolio Table 115. Kite Pharma, Inc Recent Development Table 116. sartorius Company Information Table 117. sartorius Business Overview Table 118. sartorius CAR-T Cell Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. sartorius CAR-T Cell Service Product Portfolio Table 120. sartorius Recent Development Table 121. WuXi ATU Co Company Information Table 122. WuXi ATU Co Business Overview Table 123. WuXi ATU Co CAR-T Cell Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. WuXi ATU Co CAR-T Cell Service Product Portfolio Table 125. WuXi ATU Co Recent Development Table 126. North America CAR-T Cell Service Revenue by Type (2021-2026) & (US$ Million) Table 127. North America CAR-T Cell Service Revenue by Type (2027-2032) & (US$ Million) Table 128. North America CAR-T Cell Service Revenue by Application (2021-2026) & (US$ Million) Table 129. North America CAR-T Cell Service Revenue by Application (2027-2032) & (US$ Million) Table 130. North America CAR-T Cell Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America CAR-T Cell Service Revenue by Country (2021-2026) & (US$ Million) Table 132. North America CAR-T Cell Service Revenue by Country (US$ Million) & (2027-2032) Table 133. Europe CAR-T Cell Service Revenue by Type (2021-2026) & (US$ Million) Table 134. Europe CAR-T Cell Service Revenue by Type (2027-2032) & (US$ Million) Table 135. Europe CAR-T Cell Service Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe CAR-T Cell Service Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe CAR-T Cell Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe CAR-T Cell Service Revenue by Country (2021-2026) & (US$ Million) Table 139. Europe CAR-T Cell Service Revenue by Country (US$ Million) & (2027-2032) Table 140. China CAR-T Cell Service Revenue by Type (2021-2026) & (US$ Million) Table 141. China CAR-T Cell Service Revenue by Type (2027-2032) & (US$ Million) Table 142. China CAR-T Cell Service Revenue by Application (2021-2026) & (US$ Million) Table 143. China CAR-T Cell Service Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia CAR-T Cell Service Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia CAR-T Cell Service Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia CAR-T Cell Service Revenue by Application (2021-2026) & (US$ Million) Table 147. Asia CAR-T Cell Service Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia CAR-T Cell Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia CAR-T Cell Service Revenue by Region (US$ Million) & (2021-2026) Table 150. Asia CAR-T Cell Service Revenue by Region (US$ Million) & (2027-2032) Table 151. SAMEA CAR-T Cell Service Revenue by Type (2021-2026) & (US$ Million) Table 152. SAMEA CAR-T Cell Service Revenue by Type (2027-2032) & (US$ Million) Table 153. SAMEA CAR-T Cell Service Revenue by Application (2021-2026) & (US$ Million) Table 154. SAMEA CAR-T Cell Service Revenue by Application (2027-2032) & (US$ Million) Table 155. SAMEA CAR-T Cell Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. SAMEA CAR-T Cell Service Revenue by Country (2021-2026) & (US$ Million) Table 157. SAMEA CAR-T Cell Service Revenue by Country (US$ Million) & (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. CAR-T Cell Service Image Figure 2. Global CAR-T Cell Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global CAR-T Cell Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Development Services Image Figure 5. Manufacturing Services Image Figure 6. Other Image Figure 7. Global CAR-T Cell Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global CAR-T Cell Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinical Research Image Figure 10. Clinical Treatment Image Figure 11. Other Image Figure 12. Global CAR-T Cell Service Market Size (US$ Million) & (2021-2032) Figure 13. Global CAR-T Cell Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global CAR-T Cell Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global CAR-T Cell Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global CAR-T Cell Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global CAR-T Cell Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global CAR-T Cell Service Revenue Market Share by Type (2021-2032) Figure 20. Global CAR-T Cell Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global CAR-T Cell Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global CAR-T Cell Service Revenue Market Share by Application (2021-2032) Figure 23. North America CAR-T Cell Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America CAR-T Cell Service Revenue Share by Type (2021-2032) Figure 25. North America CAR-T Cell Service Revenue Share by Application (2021-2032) Figure 26. North America CAR-T Cell Service Revenue Share by Country (2021-2032) Figure 27. United States CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe CAR-T Cell Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe CAR-T Cell Service Revenue Share by Type (2021-2032) Figure 32. Europe CAR-T Cell Service Revenue Share by Application (2021-2032) Figure 33. Europe CAR-T Cell Service Revenue Share by Country (2021-2032) Figure 34. Germany CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China CAR-T Cell Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China CAR-T Cell Service Revenue Share by Type (2021-2032) Figure 44. China CAR-T Cell Service Revenue Share by Application (2021-2032) Figure 45. Asia CAR-T Cell Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia CAR-T Cell Service Revenue Share by Type (2021-2032) Figure 47. Asia CAR-T Cell Service Revenue Share by Application (2021-2032) Figure 48. Asia CAR-T Cell Service Revenue Share by Region (2021-2032) Figure 49. Japan CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA CAR-T Cell Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA CAR-T Cell Service Revenue Share by Type (2021-2032) Figure 57. SAMEA CAR-T Cell Service Revenue Share by Application (2021-2032) Figure 58. SAMEA CAR-T Cell Service Revenue Share by Country (2021-2032) Figure 59. Brazil CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt CAR-T Cell Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Development Services
  • Manufacturing Services
  • Other
Applications
  • Clinical Research
  • Clinical Treatment
  • Other
Companies covered
  • Aurigene Pharmaceutical Services Ltd
  • Cellipont Bioservices
  • ProBio
  • Creative Biolabs
  • Charles River Laboratories
  • Cytiva
  • Sino Biological, Inc
  • Miltenyi Biotec
  • ProMab Biotechnologies, Inc
  • Creative Biogene
  • BPS Bioscience, Inc
  • Reaction Biology
  • Cusabio Technology LLC
  • Oncodesign Services
  • ACROBiosystems
  • Kite Pharma, Inc
  • sartorius
  • WuXi ATU Co

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 CAR-T Cell Service Market by Type
  3. 1.2.1 Global CAR-T Cell Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Development Services
  5. 1.2.3 Manufacturing Services
  6. 1.2.4 Other
  7. 1.3 CAR-T Cell Service Market by Application
  8. 1.3.1 Global CAR-T Cell Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinical Research
  10. 1.3.3 Clinical Treatment
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 CAR-T Cell Service Market Dynamics
  1. 2.1 CAR-T Cell Service Industry Trends
  2. 2.2 CAR-T Cell Service Industry Drivers
  3. 2.3 CAR-T Cell Service Industry Opportunities and Challenges
  4. 2.4 CAR-T Cell Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global CAR-T Cell Service Market Perspective (2021-2032)
  2. 3.2 Global CAR-T Cell Service Growth Trends by Region
  3. 3.2.1 Global CAR-T Cell Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global CAR-T Cell Service Market Size by Region (2021-2026)
  5. 3.2.3 Global CAR-T Cell Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global CAR-T Cell Service Revenue by Players
  2. 4.1.1 Global CAR-T Cell Service Revenue by Players (2021-2026)
  3. 4.1.2 Global CAR-T Cell Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global CAR-T Cell Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global CAR-T Cell Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global CAR-T Cell Service Key Players Headquarters & Area Served
  7. 4.4 Global CAR-T Cell Service Players, Product Type & Application
  8. 4.5 Global CAR-T Cell Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global CAR-T Cell Service Market CR5 and HHI
  11. 4.6.3 2025 CAR-T Cell Service Tier 1, Tier 2, and Tier 3
5 CAR-T Cell Service Market Size by Type
  1. 5.1 Global CAR-T Cell Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global CAR-T Cell Service Revenue by Type (2021-2032)
  3. 5.3 Global CAR-T Cell Service Revenue Market Share by Type (2021-2032)
6 CAR-T Cell Service Market Size by Application
  1. 6.1 Global CAR-T Cell Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global CAR-T Cell Service Revenue by Application (2021-2032)
  3. 6.3 Global CAR-T Cell Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Aurigene Pharmaceutical Services Ltd
  2. 7.1.1 Aurigene Pharmaceutical Services Ltd Company Information
  3. 7.1.2 Aurigene Pharmaceutical Services Ltd Business Overview
  4. 7.1.3 Aurigene Pharmaceutical Services Ltd CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Aurigene Pharmaceutical Services Ltd CAR-T Cell Service Product Portfolio
  6. 7.1.5 Aurigene Pharmaceutical Services Ltd Recent Developments
  7. 7.2 Cellipont Bioservices
  8. 7.2.1 Cellipont Bioservices Company Information
  9. 7.2.2 Cellipont Bioservices Business Overview
  10. 7.2.3 Cellipont Bioservices CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Cellipont Bioservices CAR-T Cell Service Product Portfolio
  12. 7.2.5 Cellipont Bioservices Recent Developments
  13. 7.3 ProBio
  14. 7.3.1 ProBio Company Information
  15. 7.3.2 ProBio Business Overview
  16. 7.3.3 ProBio CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 ProBio CAR-T Cell Service Product Portfolio
  18. 7.3.5 ProBio Recent Developments
  19. 7.4 Creative Biolabs
  20. 7.4.1 Creative Biolabs Company Information
  21. 7.4.2 Creative Biolabs Business Overview
  22. 7.4.3 Creative Biolabs CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Creative Biolabs CAR-T Cell Service Product Portfolio
  24. 7.4.5 Creative Biolabs Recent Developments
  25. 7.5 Charles River Laboratories
  26. 7.5.1 Charles River Laboratories Company Information
  27. 7.5.2 Charles River Laboratories Business Overview
  28. 7.5.3 Charles River Laboratories CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Charles River Laboratories CAR-T Cell Service Product Portfolio
  30. 7.5.5 Charles River Laboratories Recent Developments
  31. 7.6 Cytiva
  32. 7.6.1 Cytiva Company Information
  33. 7.6.2 Cytiva Business Overview
  34. 7.6.3 Cytiva CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cytiva CAR-T Cell Service Product Portfolio
  36. 7.6.5 Cytiva Recent Developments
  37. 7.7 Sino Biological, Inc
  38. 7.7.1 Sino Biological, Inc Company Information
  39. 7.7.2 Sino Biological, Inc Business Overview
  40. 7.7.3 Sino Biological, Inc CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sino Biological, Inc CAR-T Cell Service Product Portfolio
  42. 7.7.5 Sino Biological, Inc Recent Developments
  43. 7.8 Miltenyi Biotec
  44. 7.8.1 Miltenyi Biotec Company Information
  45. 7.8.2 Miltenyi Biotec Business Overview
  46. 7.8.3 Miltenyi Biotec CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Miltenyi Biotec CAR-T Cell Service Product Portfolio
  48. 7.8.5 Miltenyi Biotec Recent Developments
  49. 7.9 ProMab Biotechnologies, Inc
  50. 7.9.1 ProMab Biotechnologies, Inc Company Information
  51. 7.9.2 ProMab Biotechnologies, Inc Business Overview
  52. 7.9.3 ProMab Biotechnologies, Inc CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 ProMab Biotechnologies, Inc CAR-T Cell Service Product Portfolio
  54. 7.9.5 ProMab Biotechnologies, Inc Recent Developments
  55. 7.10 Creative Biogene
  56. 7.10.1 Creative Biogene Company Information
  57. 7.10.2 Creative Biogene Business Overview
  58. 7.10.3 Creative Biogene CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Creative Biogene CAR-T Cell Service Product Portfolio
  60. 7.10.5 Creative Biogene Recent Developments
  61. 7.11 BPS Bioscience, Inc
  62. 7.11.1 BPS Bioscience, Inc Company Information
  63. 7.11.2 BPS Bioscience, Inc Business Overview
  64. 7.11.3 BPS Bioscience, Inc CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 BPS Bioscience, Inc CAR-T Cell Service Product Portfolio
  66. 7.11.5 BPS Bioscience, Inc Recent Developments
  67. 7.12 Reaction Biology
  68. 7.12.1 Reaction Biology Company Information
  69. 7.12.2 Reaction Biology Business Overview
  70. 7.12.3 Reaction Biology CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Reaction Biology CAR-T Cell Service Product Portfolio
  72. 7.12.5 Reaction Biology Recent Developments
  73. 7.13 Cusabio Technology LLC
  74. 7.13.1 Cusabio Technology LLC Company Information
  75. 7.13.2 Cusabio Technology LLC Business Overview
  76. 7.13.3 Cusabio Technology LLC CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cusabio Technology LLC CAR-T Cell Service Product Portfolio
  78. 7.13.5 Cusabio Technology LLC Recent Developments
  79. 7.14 Oncodesign Services
  80. 7.14.1 Oncodesign Services Company Information
  81. 7.14.2 Oncodesign Services Business Overview
  82. 7.14.3 Oncodesign Services CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Oncodesign Services CAR-T Cell Service Product Portfolio
  84. 7.14.5 Oncodesign Services Recent Developments
  85. 7.15 ACROBiosystems
  86. 7.15.1 ACROBiosystems Company Information
  87. 7.15.2 ACROBiosystems Business Overview
  88. 7.15.3 ACROBiosystems CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 ACROBiosystems CAR-T Cell Service Product Portfolio
  90. 7.15.5 ACROBiosystems Recent Developments
  91. 7.16 Kite Pharma, Inc
  92. 7.16.1 Kite Pharma, Inc Company Information
  93. 7.16.2 Kite Pharma, Inc Business Overview
  94. 7.16.3 Kite Pharma, Inc CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Kite Pharma, Inc CAR-T Cell Service Product Portfolio
  96. 7.16.5 Kite Pharma, Inc Recent Developments
  97. 7.17 sartorius
  98. 7.17.1 sartorius Company Information
  99. 7.17.2 sartorius Business Overview
  100. 7.17.3 sartorius CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 sartorius CAR-T Cell Service Product Portfolio
  102. 7.17.5 sartorius Recent Developments
  103. 7.18 WuXi ATU Co
  104. 7.18.1 WuXi ATU Co Company Information
  105. 7.18.2 WuXi ATU Co Business Overview
  106. 7.18.3 WuXi ATU Co CAR-T Cell Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 WuXi ATU Co CAR-T Cell Service Product Portfolio
  108. 7.18.5 WuXi ATU Co Recent Developments
8 North America
  1. 8.1 North America CAR-T Cell Service Revenue (2021-2032)
  2. 8.2 North America CAR-T Cell Service Revenue by Type (2021-2032)
  3. 8.2.1 North America CAR-T Cell Service Revenue by Type (2021-2026)
  4. 8.2.2 North America CAR-T Cell Service Revenue by Type (2027-2032)
  5. 8.3 North America CAR-T Cell Service Revenue Share by Type (2021-2032)
  6. 8.4 North America CAR-T Cell Service Revenue by Application (2021-2032)
  7. 8.4.1 North America CAR-T Cell Service Revenue by Application (2021-2026)
  8. 8.4.2 North America CAR-T Cell Service Revenue by Application (2027-2032)
  9. 8.5 North America CAR-T Cell Service Revenue Share by Application (2021-2032)
  10. 8.6 North America CAR-T Cell Service Revenue by Country
  11. 8.6.1 North America CAR-T Cell Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America CAR-T Cell Service Revenue by Country (2021-2026)
  13. 8.6.3 North America CAR-T Cell Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe CAR-T Cell Service Revenue (2021-2032)
  2. 9.2 Europe CAR-T Cell Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe CAR-T Cell Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe CAR-T Cell Service Revenue by Type (2027-2032)
  5. 9.3 Europe CAR-T Cell Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe CAR-T Cell Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe CAR-T Cell Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe CAR-T Cell Service Revenue by Application (2027-2032)
  9. 9.5 Europe CAR-T Cell Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe CAR-T Cell Service Revenue by Country
  11. 9.6.1 Europe CAR-T Cell Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe CAR-T Cell Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe CAR-T Cell Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China CAR-T Cell Service Revenue (2021-2032)
  2. 10.2 China CAR-T Cell Service Revenue by Type (2021-2032)
  3. 10.2.1 China CAR-T Cell Service Revenue by Type (2021-2026)
  4. 10.2.2 China CAR-T Cell Service Revenue by Type (2027-2032)
  5. 10.3 China CAR-T Cell Service Revenue Share by Type (2021-2032)
  6. 10.4 China CAR-T Cell Service Revenue by Application (2021-2032)
  7. 10.4.1 China CAR-T Cell Service Revenue by Application (2021-2026)
  8. 10.4.2 China CAR-T Cell Service Revenue by Application (2027-2032)
  9. 10.5 China CAR-T Cell Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia CAR-T Cell Service Revenue (2021-2032)
  2. 11.2 Asia CAR-T Cell Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia CAR-T Cell Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia CAR-T Cell Service Revenue by Type (2027-2032)
  5. 11.3 Asia CAR-T Cell Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia CAR-T Cell Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia CAR-T Cell Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia CAR-T Cell Service Revenue by Application (2027-2032)
  9. 11.5 Asia CAR-T Cell Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia CAR-T Cell Service Revenue by Country
  11. 11.6.1 Asia CAR-T Cell Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia CAR-T Cell Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia CAR-T Cell Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA CAR-T Cell Service Revenue (2021-2032)
  2. 12.2 SAMEA CAR-T Cell Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA CAR-T Cell Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA CAR-T Cell Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA CAR-T Cell Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA CAR-T Cell Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA CAR-T Cell Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA CAR-T Cell Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA CAR-T Cell Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA CAR-T Cell Service Revenue by Country
  11. 12.6.1 SAMEA CAR-T Cell Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA CAR-T Cell Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA CAR-T Cell Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst